Cash flow Legend Biotech Corporation

Equities

LEGN

US52490G1022

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 18:40:20 06/03/2026 GMT			5-day change	1st Jan Change
18.96 ^USD	+6.79%		-0.84%	-13.34%

02-23	Gilead to buy cancer therapy developer Arcellx for up to $7.8 billion	RE
02-12	Legend Biotech Shares Lower After Rothschild & Co Redburn Downgrade	MT

9.ANdlKRcNlQiPjSPedLZ8PMpnIgGaNP-T3qWamTM6i1s.QuYRREN-1GXm4lHmMoMRXa1UV0veBLjyitTp4wpzww9nuQARVUrlV9vUdg

Published financial data: LEGEND BIOTECH CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	75.68M	89.79M	117M	285M	621M
Other Revenues, Total	3.07M	1.77M	328K	179K	6.26M
Total Revenues	78.75M	91.56M	117M	285M	627M
Cost of Goods Sold, Total	-	-	401M	526M	648M
Gross Profit	78.75M	91.56M	-284M	-241M	-20.88M
Selling General & Admin Expenses, Total	72.72M	149M	174M	201M	284M
R&D Expenses	232M	313M	-	-	-
Other Operating Expenses	-4K	-	-	-	-
Other Operating Expenses, Total	305M	463M	174M	201M	284M
Operating Income	-226M	-371M	-458M	-442M	-305M
Interest Expense, Total	-195K	-900K	-10.8M	-21.79M	-21.62M
Interest And Investment Income	2.93M	971K	8.18M	54.49M	61.2M
Net Interest Expenses	2.74M	71K	-2.61M	32.69M	39.59M
Currency Exchange Gains (Loss)	66K	-	-	-	109M
Other Non Operating Income (Expenses)	-4.36M	-14.04M	14.82M	-111M	3.34M
EBT, Excl. Unusual Items	-228M	-385M	-446M	-521M	-154M
Gain (Loss) On Sale Of Investments	47K	-	603K	663K	-
Gain (Loss) On Sale Of Assets	-	-974K	-481K	-226K	-
Asset Writedown	-	-	-	-	-4.42M
Other Unusual Items	-79.98M	-	-	-	-
EBT, Incl. Unusual Items	-308M	-386M	-446M	-520M	-158M
Income Tax Expense	-4.14M	1K	625K	-1.86M	18.89M
Earnings From Continuing Operations	-303M	-386M	-446M	-518M	-177M
Net Income to Company	-303M	-386M	-446M	-518M	-177M
Net Income - (IS)	-303M	-386M	-446M	-518M	-177M
Net Income to Common Incl Extra Items	-303M	-386M	-446M	-518M	-177M
Net Income to Common Excl. Extra Items	-303M	-386M	-446M	-518M	-177M
Per Share Items
Net EPS - Basic	-2.57	-2.74	-2.81	-2.94	-0.97
Basic EPS - Continuing Operations	-2.57	-2.74	-2.81	-2.94	-0.97
Basic Weighted Average Shares Outstanding	118M	141M	159M	176M	183M
Net EPS - Diluted	-2.57	-2.74	-2.81	-2.94	-0.97
Diluted EPS - Continuing Operations	-2.57	-2.74	-2.81	-2.94	-0.97
Diluted Weighted Average Shares Outstanding	118M	141M	159M	176M	183M
Normalized Basic EPS	-1.2	-1.71	-1.75	-1.85	-0.53
Normalized Diluted EPS	-1.2	-1.71	-1.75	-1.85	-0.53
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	-218M	-360M	-448M	-432M	-294M
EBITA	-226M	-371M	-458M	-442M	-305M
EBIT	-226M	-371M	-458M	-442M	-305M
EBITDAR	-	-360M	-447M	-429M	-291M
Total Revenues (As Reported)	-	-	117M	285M	627M
Effective Tax Rate - (Ratio)	1.35	-0	-0.14	0.36	-11.95
Current Domestic Taxes	-3.61M	-	224K	511K	997K
Current Foreign Taxes	-532K	1K	401K	-2.38M	17.9M
Total Current Taxes	-4.14M	1K	625K	-1.86M	18.89M
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-142M	-241M	-279M	-325M	-96.07M
Interest on Long-Term Debt	195K	142K	527K	1.39M	1.77M
Supplemental Operating Expense Items
Selling and Marketing Expenses	49.57M	103M	93.42M	94.16M	147M
General and Administrative Expenses	23.15M	46.94M	80.63M	107M	137M
Research And Development Expense From Footnotes	232M	313M	336M	382M	414M
Net Rental Expense, Total	-	182K	1.13M	2.34M	3.5M
Imputed Operating Lease Interest Expense	-	20.69K	480K	1.33M	1.78M
Imputed Operating Lease Depreciation	-	161K	652K	1.01M	1.72M
Stock-Based Comp., Other (Total)	4.76M	20.16M	34.34M	47.68M	68.94M
Total Stock-Based Compensation	4.76M	20.16M	34.34M	47.68M	68.94M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	456M	689M	786M	1.28B	287M
Short Term Investments	50M	193M	54.02M	30.34M	836M
Trading Asset Securities, Total	-	-	186M	663K	-
Total Cash And Short Term Investments	506M	882M	1.03B	1.31B	1.12B
Accounts Receivable, Total	74.98M	50.41M	278K	101M	6.86M
Other Receivables	6.55M	7.04M	45.24M	55.63M	118M
Total Receivables	81.53M	57.45M	45.52M	157M	125M
Inventory	1.8M	1.75M	10.35M	19.43M	23.9M
Prepaid Expenses	3.46M	5.72M	16.33M	12.23M	12.37M
Other Current Assets, Total	384K	1.44M	1.27M	357K	70K
Total Current Assets	593M	949M	1.1B	1.5B	1.28B
Gross Property Plant And Equipment	135M	176M	186M	224M	245M
Accumulated Depreciation	-13.41M	-22.63M	-25.21M	-35M	-43.66M
Net Property Plant And Equipment	121M	153M	161M	189M	201M
Long-term Investments	-	4.7M	-	4.36M	4.36M
Other Intangibles, Total	2.85M	4.68M	3.41M	4.06M	2.16M
Accounts Receivable Long-Term	-	-	395K	285K	-
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	4.2M	7.32M	67.28M	153M	178M
Total Assets	721M	1.12B	1.33B	1.85B	1.67B
Liabilities
Accounts Payable, Total	4.91M	7.04M	32.89M	20.16M	38.59M
Accrued Expenses, Total	13.61M	106M	153M	105M	64.51M
Short-term Borrowings	327K	-	-	-	-
Current Portion of Leases	1.46M	911K	3.56M	3.18M	4.79M
Current Income Taxes Payable	-	515K	9.77M	7.2M	20.67M
Unearned Revenue Current, Total	55.3M	60.95M	451K	53.08M	47.41M
Other Current Liabilities	85.56M	105M	98.38M	27.39M	102M
Total Current Liabilities	161M	280M	298M	216M	278M
Long-Term Debt	-	120M	261M	281M	301M
Long-Term Leases	1.91M	1.59M	20.04M	44.17M	44.61M
Unearned Revenue Non Current	277M	244M	7.66M	55.27M	6.15M
Other Non Current Liabilities	554K	396K	233K	56K	-
Total Liabilities	441M	647M	587M	597M	630M
Common Stock, Total	27K	31K	33K	36K	37K
Additional Paid In Capital	708M	1.26B	1.66B	2.64B	2.7B
Retained Earnings	-431M	-817M	-966M	-1.48B	-1.66B
Comprehensive Income and Other	2.68M	26.69M	53.72M	98.92M	6.27M
Total Common Equity	280M	471M	744M	1.25B	1.04B
Total Equity	280M	471M	744M	1.25B	1.04B
Total Liabilities And Equity	721M	1.12B	1.33B	1.85B	1.67B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	133M	154M	165M	182M	184M
ECS Total Common Shares Outstanding	133M	154M	165M	182M	184M
Book Value / Share	2.11	3.06	4.51	6.88	5.67
Tangible Book Value	277M	467M	741M	1.25B	1.04B
Tangible Book Value Per Share	2.09	3.02	4.49	6.86	5.65
Total Debt	3.7M	123M	285M	329M	351M
Net Debt	-502M	-759M	-741M	-980M	-772M
Debt Equivalent Oper. Leases	-	1.46M	9.06M	18.7M	28.02M
Account Code - Inventory Valuation	5	6	5	5	5
Inventories - Raw Materials, Total	1.8M	1.75M	6.99M	13.16M	17.45M
Inventories - Work In Process, Total	-	-	690K	2.99M	4.44M
Inventories - Finished Goods, Total	-	-	2.68M	3.29M	2.01M
Land - (BS)	2.89M	2.89M	2.89M	2.89M	2.89M
Buildings, Total	45.83M	59.66M	45.08M	65.54M	65.54M
Machinery, Total	40.75M	52.31M	46.26M	49.14M	44.92M
Full Time Employees	882	1.07K	1.39K	1.8K	2.6K
Accumulated Allowance for Doubtful Accounts (Supple)	22K	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-303M	-386M	-446M	-518M	-177M
Depreciation & Amortization - CF	9.74M	12.54M	15.92M	18.53M	21.43M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	160K
Depreciation & Amortization, Total	9.74M	12.54M	15.92M	18.53M	21.59M
Amortization of Deferred Charges, Total - (CF)	192K	1.38M	2.48M	1.92M	1.77M
(Gain) Loss From Sale Of Asset	55K	974K	481K	226K	2K
(Gain) Loss on Sale of Investments - (CF)	-47K	-	-593K	-663K	-
Asset Writedown & Restructuring Costs	-	-	-	-	4.42M
Stock-Based Compensation (CF)	4.76M	20.16M	34.34M	47.68M	68.94M
Provision and Write-off of Bad Debts	13K	-22K	-	-	-
Other Operating Activities, Total	87.22M	11.77M	-47K	129M	-83.85M
Change In Accounts Receivable	-45M	24.59M	50.32M	-98.98M	93.75M
Change In Inventories	-643K	51K	-8.6M	-12.71M	-17.21M
Change In Accounts Payable	-4.35M	1.8M	25.85M	-12.7M	14.06M
Change in Unearned Revenues	8.48M	-22.23M	6.18M	100M	-49.61M
Change in Other Net Operating Assets	20.05M	137M	119M	-46.96M	-20.87M
Cash from Operations	-223M	-198M	-201M	-393M	-144M
Capital Expenditure	-45.75M	-43.9M	-20.93M	-20.08M	-14.1M
Sale of Property, Plant, and Equipment	1K	4K	-	-	-
Sale (Purchase) of Intangible assets	-4.03M	-3.21M	-1.35M	-2.64M	-
Investment in Marketable and Equity Securities, Total	25.56M	-148M	-41.36M	205M	-785M
Other Investing Activities, Total	47K	-	-13.45M	-89.07M	-51.88M
Cash from Investing	-24.17M	-195M	-77.09M	92.79M	-851M
Short Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-4K	-	-	-	-
Long-Term Debt Repaid, Total	-2.6M	-1.42M	-2.6M	-3.76M	-4.02M
Total Debt Repaid	-2.61M	-1.42M	-2.6M	-3.76M	-4.02M
Issuance of Common Stock	464M	628M	381M	795M	9.72M
Issuance of Preferred Stock	160M	-	-	-	-
Other Financing Activities, Total	-2.51M	-	-	-	-
Cash from Financing	619M	627M	378M	791M	5.7M
Foreign Exchange Rate Adjustments	620K	34K	-2.51M	682K	-2.08M
Net Change in Cash	372M	233M	97.09M	492M	-991M
Supplemental Items
Cash Interest Paid	195K	142K	527K	1.39M	1.77M
Cash Income Tax Paid (Refund)	-7.11M	-557K	-3.71M	-308K	1.55M
Levered Free Cash Flow	-183M	-105M	-203M	-441M	-38.58M
Unlevered Free Cash Flow	-183M	-104M	-196M	-428M	-25.07M
Change In Net Working Capital	6.35M	-141M	-59.92M	197M	-87.46M
Net Debt Issued / Repaid	-2.61M	-1.42M	-2.6M	-3.76M	-4.02M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-28.02	-25.23	-23.37	-17.38	-10.84
Return on Total Capital	-169.08	-52.85	-29.86	-21.19	-12.84
Return On Equity %	-385.65	-102.79	-59.11	-51.94	-15.45
Return on Common Equity	-385.65	-102.79	-59.11	-51.94	-15.45
Margin Analysis
Gross Profit Margin %	100	100	-242.73	-84.62	-3.33
SG&A Margin	92.34	163.25	148.75	70.47	45.32
EBITDA Margin %	-276.68	-393.41	-382.79	-151.33	-46.92
EBITA Margin %	-287.15	-405.47	-391.48	-155.09	-48.62
EBIT Margin %	-287.15	-405.47	-391.48	-155.09	-48.65
Income From Continuing Operations Margin %	-385.38	-421.8	-381.48	-181.75	-28.22
Net Income Margin %	-385.38	-421.8	-381.48	-181.75	-28.22
Net Avail. For Common Margin %	-385.38	-421.8	-381.48	-181.75	-28.22
Normalized Net Income Margin	-180.71	-262.96	-238.16	-114.1	-15.32
Levered Free Cash Flow Margin	-232.23	-114.51	-173.2	-154.73	-6.15
Unlevered Free Cash Flow Margin	-232.08	-113.9	-167.44	-149.95	-4
Asset Turnover
Asset Turnover	0.16	0.1	0.1	0.18	0.36
Fixed Assets Turnover	0.79	0.67	0.78	1.63	3.21
Receivables Turnover (Average Receivables)	1.44	1.43	4.6	5.6	11.47
Inventory Turnover (Average Inventory)	-	-	66.27	35.35	29.91
Short Term Liquidity
Current Ratio	3.68	3.39	3.69	6.92	4.62
Quick Ratio	3.64	3.35	3.6	6.77	4.49
Operating Cash Flow to Current Liabilities	-1.38	-0.71	-0.68	-1.82	-0.52
Days Sales Outstanding (Average Receivables)	253.84	254.85	79.43	65.14	31.91
Days Outstanding Inventory (Average Inventory)	-	-	5.51	10.33	12.24
Average Days Payable Outstanding	-	-	17.79	18.08	19.42
Cash Conversion Cycle (Average Days)	-	-	67.15	57.38	24.73
Long Term Solvency
Total Debt/Equity	1.32	26.1	38.23	26.26	33.69
Total Debt / Total Capital	1.3	20.7	27.66	20.8	25.2
LT Debt/Equity	0.68	25.9	37.75	26.01	33.23
Long-Term Debt / Total Capital	0.67	20.54	27.31	20.6	24.86
Total Liabilities / Total Assets	61.13	57.87	44.08	32.31	37.7
EBIT / Interest Expense	-1.16K	-412.52	-42.43	-20.29	-14.12
EBITDA / Interest Expense	-1.11K	-398.58	-40.95	-19.44	-13.12
(EBITDA - Capex) / Interest Expense	-1.34K	-447.37	-42.89	-20.36	-13.77
Total Debt / EBITDA	-0.02	-0.34	-0.64	-0.78	-1.24
Net Debt / EBITDA	2.32	2.12	1.68	2.31	2.72
Total Debt / (EBITDA - Capex)	-0.01	-0.31	-0.61	-0.74	-1.18
Net Debt / (EBITDA - Capex)	1.92	1.89	1.6	2.21	2.59
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	33.59	16.27	70	143.7	119.97
Gross Profit, 1 Yr. Growth %	33.59	16.27	16.15	-15.04	-91.34
EBITDA, 1 Yr. Growth %	66.03	65.33	16.07	-3.65	-31.8
EBITA, 1 Yr. Growth %	67.21	64.18	16.25	-3.46	-31.03
EBIT, 1 Yr. Growth %	67.21	64.18	16.25	-3.46	-31
Earnings From Cont. Operations, 1 Yr. Growth %	128.23	27.26	10.6	16.11	-65.84
Net Income, 1 Yr. Growth %	128.23	27.26	10.6	16.11	-65.84
Normalized Net Income, 1 Yr. Growth %	74.01	69.24	9.75	16.76	-70.48
Diluted EPS Before Extra, 1 Yr. Growth %	93.16	6.75	-2.05	4.87	-67.11
Accounts Receivable, 1 Yr. Growth %	150	-32.77	-99.45	36.39K	-93.24
Inventory, 1 Yr. Growth %	55.57	-2.83	492	87.69	23
Net Property, Plant and Equip., 1 Yr. Growth %	52.47	26.27	14.18	17.71	6.34
Total Assets, 1 Yr. Growth %	150.6	55.11	18.89	38.89	-9.65
Tangible Book Value, 1 Yr. Growth %	-324.82	68.17	-2.67	68.35	-16.75
Common Equity, 1 Yr. Growth %	-328.09	68.13	-2.82	68.12	-16.85
Cash From Operations, 1 Yr. Growth %	168.47	-11	1.42	95.39	-63.38
Capital Expenditures, 1 Yr. Growth %	18.41	-4.03	-50.41	-4.03	-29.77
Levered Free Cash Flow, 1 Yr. Growth %	111.37	-42.67	64.98	117.7	-91.26
Unlevered Free Cash Flow, 1 Yr. Growth %	111.57	-42.94	60.22	118.25	-94.14
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	26.14	24.49	24.9	103.54	131.53
Gross Profit, 2 Yr. CAGR %	26.14	24.49	34.43	-0.66	-72.88
EBITDA, 2 Yr. CAGR %	291.34	65.68	41.52	5.75	-18.72
EBITA, 2 Yr. CAGR %	287.34	65.69	41.16	5.94	-18.18
EBIT, 2 Yr. CAGR %	287.34	65.69	41.16	5.94	-18.38
Earnings From Cont. Operations, 2 Yr. CAGR %	944.07	70.42	29.45	13.32	-37.02
Net Income, 2 Yr. CAGR %	944.07	70.42	29.45	13.32	-37.02
Normalized Net Income, 2 Yr. CAGR %	1.06K	71.59	39.75	13.2	-41.32
Diluted EPS Before Extra, 2 Yr. CAGR %	860.52	43.6	11.44	1.35	-41.27
Accounts Receivable, 2 Yr. CAGR %	69.1	29.65	-93.94	41.72	396.57
Inventory, 2 Yr. CAGR %	25.93	22.95	139.84	233.33	51.94
Net Property, Plant and Equip., 2 Yr. CAGR %	94.88	38.75	19.87	15.93	11.88
Total Assets, 2 Yr. CAGR %	29.63	97.16	35.76	28.5	12.02
Tangible Book Value, 2 Yr. CAGR %	467.95	94.45	11.6	28	18.39
Common Equity, 2 Yr. CAGR %	469.24	95.83	11.59	27.82	18.24
Cash From Operations, 2 Yr. CAGR %	-14.87	54.57	-5	40.77	-15.41
Capital Expenditures, 2 Yr. CAGR %	47.74	6.6	-10.72	-31.01	-17.9
Levered Free Cash Flow, 2 Yr. CAGR %	-3.5	10.08	9.19	89.52	-56.37
Unlevered Free Cash Flow, 2 Yr. CAGR %	-3.55	9.87	7.4	87	-64.23
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	49.24	22.76	23.71	56.08	108.88
Gross Profit, 3 Yr. CAGR %	49.24	22.76	66.26	15.36	-55.96
EBITDA, 3 Yr. CAGR %	149.19	193.64	51.29	24.5	-8.64
EBITA, 3 Yr. CAGR %	153.52	190.96	51.2	24.37	-8.18
EBIT, 3 Yr. CAGR %	153.52	190.96	51.2	24.37	-8.17
Earnings From Cont. Operations, 3 Yr. CAGR %	218.82	417.67	63.79	24.84	-24.02
Net Income, 3 Yr. CAGR %	218.82	417.67	63.79	24.84	-24.02
Normalized Net Income, 3 Yr. CAGR %	154.35	509.07	51.67	31.62	-27.67
Diluted EPS Before Extra, 3 Yr. CAGR %	291.51	361.81	40.13	9.2	-30.35
Accounts Receivable, 3 Yr. CAGR %	-30.97	24.34	-79	10.28	-48.61
Inventory, 3 Yr. CAGR %	446.97	15.5	107.61	121.02	139.09
Net Property, Plant and Equip., 3 Yr. CAGR %	245.79	68.63	30.11	19.14	12.64
Total Assets, 3 Yr. CAGR %	44.56	37.62	65.69	36.8	14.27
Tangible Book Value, 3 Yr. CAGR %	183.58	278.55	70	27.99	10.9
Common Equity, 3 Yr. CAGR %	184.53	279.1	70.07	27.92	10.75
Cash From Operations, 3 Yr. CAGR %	354.45	-13.6	34.32	20.82	-10.13
Capital Expenditures, 3 Yr. CAGR %	272.93	27.95	-7.88	-8.54	-30.6
Levered Free Cash Flow, 3 Yr. CAGR %	-	-18.88	22.08	37.43	-32.03
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-19.03	20.76	36.03	-41.04
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	37.63	41.94	58.96
Gross Profit, 5 Yr. CAGR %	-	-	64.34	37.28	-19.51
EBITDA, 5 Yr. CAGR %	-	-	99.76	97.87	17.87
EBITA, 5 Yr. CAGR %	-	-	101.24	96.56	18.14
EBIT, 5 Yr. CAGR %	-	-	101.24	96.56	18.15
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	116.59	184.43	11.75
Net Income, 5 Yr. CAGR %	-	-	116.59	184.43	11.75
Normalized Net Income, 5 Yr. CAGR %	-	-	100.28	214.01	3.76
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	130.86	154	-1.04
Accounts Receivable, 5 Yr. CAGR %	-	-	-73.87	31.07	-25.56
Inventory, 5 Yr. CAGR %	-	-	293.32	76.49	83.24
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	122.79	42.78	22.49
Total Assets, 5 Yr. CAGR %	-	-	41.02	33.93	41.67
Tangible Book Value, 5 Yr. CAGR %	-	-	127.48	170.58	47.09
Common Equity, 5 Yr. CAGR %	-	-	127.68	170.45	47.05
Cash From Operations, 5 Yr. CAGR %	-	-	142.99	5.03	11.64
Capital Expenditures, 5 Yr. CAGR %	-	-	88.39	-0.85	-12.03
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	17.57	-19.11
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	16.83	-25.77